Literature DB >> 15680399

Truncated ALK derived from chromosomal translocation t(2;5)(p23;q35) binds to the SH3 domain of p85-PI3K.

Doris Polgar1, Christina Leisser, Susanne Maier, Stephan Strasser, Beate Rüger, Markus Dettke, Maya Khorchide, Ingrid Simonitsch, Christa Cerni, Georg Krupitza.   

Abstract

The chromosomal translocation t(2;5)(p23;q35) is associated with "Anaplastic large cell lymphomas" (ALCL), a Non Hodgkin Lymphoma occurring in childhood. The fusion of the tyrosine kinase gene-ALK (anaplastic lymphoma kinase) on chromosome 2p23 to the NPM (nucleophosmin/B23) gene on chromosome 5q35 results in a 80 kDa chimeric protein, which activates the "survival" kinase PI3K. However, the binding mechanism between truncated ALK and PI3K is poorly understood. Therefore, we attempted to elucidate the molecular interaction between ALK and the regulatory p85 subunit of PI3K. Here we provide evidence that the truncated ALK homodimer binds to the SH3 domain of p85. This finding may be useful for the development of a new target-specific intervention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15680399     DOI: 10.1016/j.mrfmmm.2004.09.011

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  Role of the p55-gamma subunit of PI3K in ALK-induced cell migration: RNAi-based selection of cell migration regulators.

Authors:  Minchul Seo; Jong-Heon Kim; Kyoungho Suk
Journal:  Cell Adh Migr       Date:  2016-06-20       Impact factor: 3.405

2.  Coupling an EML4-ALK-centric interactome with RNA interference identifies sensitizers to ALK inhibitors.

Authors:  Guolin Zhang; Hannah Scarborough; Jihye Kim; Andrii I Rozhok; Yian Ann Chen; Xiaohui Zhang; Lanxi Song; Yun Bai; Bin Fang; Richard Z Liu; John Koomen; Aik Choon Tan; James Degregori; Eric B Haura
Journal:  Sci Signal       Date:  2016-10-18       Impact factor: 8.192

3.  Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth.

Authors:  Ludovica Riera; Elena Lasorsa; Chiara Ambrogio; Nadia Surrenti; Claudia Voena; Roberto Chiarle
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

4.  Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression.

Authors:  Xuchao Zhang; Shirley Zhang; Xuening Yang; Jinji Yang; Qing Zhou; Lucy Yin; Shejuan An; Jiaying Lin; Shiliang Chen; Zhi Xie; Mike Zhu; Xiaolin Zhang; Yi-long Wu
Journal:  Mol Cancer       Date:  2010-07-13       Impact factor: 27.401

5.  Epigenetic deregulation of the anaplastic lymphoma kinase gene modulates mesenchymal characteristics of oral squamous cell carcinomas.

Authors:  Tze-Ta Huang; Cara B Gonzales; Fei Gu; Ya-Ting Hsu; Rohit R Jadhav; Chiou-Miin Wang; Spencer W Redding; Chih-En Tseng; Ching-Chih Lee; Ian M Thompson; Hau-Ren Chen; Tim Hui-Ming Huang; Nameer B Kirma
Journal:  Carcinogenesis       Date:  2013-04-08       Impact factor: 4.944

Review 6.  [The EML4-ALK fusion gene in NSCLC and the clinical progress].

Authors:  Di Wu; Hong Yu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-05

Review 7.  Anaplastic lymphoma kinase: signalling in development and disease.

Authors:  Ruth H Palmer; Emma Vernersson; Caroline Grabbe; Bengt Hallberg
Journal:  Biochem J       Date:  2009-05-27       Impact factor: 3.857

8.  NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases.

Authors:  Joel D Pearson; Jason K H Lee; Julinor T C Bacani; Raymond Lai; Robert J Ingham
Journal:  J Signal Transduct       Date:  2012-07-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.